HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 3 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH Plaintiff, y. ORDER TO SHOW CAUSE NURIX THERAPEUTICS, INC., Defendant. 9 Plaintiff/Counterclaim Defendant HotSpot Therapeutics, Inc. moves for partial summary || judgment in its favor that Defendant/Counterclaim Plaintiff Nurix Therapeutics, Inc.’s trade secret ( misappropriation claims are barred by the applicable three-year statute of limitations. ECF No. 189. Nurix failed to file an opposition in compliance with Civil Local Rule 7. The Court || possesses the inherent power to dismiss an action sua sponte “to achieve the orderly and 15. || expeditious disposition of cases.” Link v. Wabash R.R. Co., 370 U.S. 626, 629-33 (1962). Accordingly, the Court hereby VACATES the March 14, 2024 noticed hearing date and ORDERS Nurix to show cause why its claims should not be dismissed for failure to prosecute and failure to comply with court…